Join us at Luminesce Alliance 2024 Conference: Paediatric Precision Medicine: Advancing Research and Patient Care 

Join us for the Luminesce Alliance 2024 Conference – Paediatric Precision Medicine: Advancing Research and Patient Care at the UNSW Sydney, Australia from 7–8 November 2024.

The aim of the conference is to showcase innovation, collaboration, and excellence in precision medicine research. Together we will explore the latest developments in basic, translational, and clinical research concerning children and families grappling with rare genetic diseases and cancers.

The conference brings together a wide range of researchers and clinicians including, post-graduate students, early career Fellows, nurses, allied healthcare workers, as well as government and the MedTech and Pharma industries.

We encourage you to visit the Luminesce Alliance 2024 Conference website and register your interest to receive updates including call for abstracts, call for sponsorship and early bird registration opportunities.

Announcing our first sponsor

UNSW Sydney is a global top 20 university, known for innovative, pioneering research and high-quality education with a global impact. Since our foundation in 1949, our aim has been to improve and transform lives through excellence in research, outstanding education and a commitment to advancing a just society.

Announcing our first keynote speakers

We are pleased to welcome our first keynote speakers for the 2024 conference.

Professor Elaine Mardis, PhD
Co-Executive Director of the Steve and Cindy Rasmussen Institute for Genomic Medicine

Dr. Elaine Mardis, PhD, is the co-Executive Director of the Steve and Cindy Rasmussen Institute for Genomic Medicine at Nationwide Children’s Hospital, holding the Rasmussen Nationwide Foundation Endowed Chair in Genomic Medicine. Additionally, she is a Professor of Paediatrics at The Ohio State University College of Medicine. An expert in cancer genomics and immunogenomics, she has over 430 published manuscripts.


Professor Neil Sebire
Professor of Pathology GOSH UCL and Chief Research Information Officer (CRIO)
Director of the GOSH Clinical Informatics Research Programme

Neil Sebire, Professor of pathology at Great Ormond Street Hospital Institute of Child Health, is a prolific clinical academic with over 1000 publications. Specializing in clinical informatics and secondary use of health data, he serves as the chief research information officer at Great Ormond Street Hospital and was the first national chief clinical data officer for Health Data Research UK. Leading the GOSH clinical informatics research program, he oversees more than 20 PhD students in this field.


Professor Gary L. Free MD, MPH
Percy and Mary Murphy Professor of Pediatrics Professor of Health Management and Policy
Director, Program on Equity for Adolescent and Child Health (PEACH)
Director, Michigan Child Health Equity Collaborative (MI-CHEC)

Gary L. Freed MD, MPH is the Percy and Mary Murphy Professor of Pediatrics in the School of Medicine and Professor of Health Management and Policy in the School of Public Health at the University of Michigan. He serves as Associate Chair for Government Relations in the Department of Pediatrics and the Directory of Research for the Office for Health Equity and Inclusion in the Medical School.


Adjunct Professor Jean-Frédéric Levesque, MD PHD FRCP
Deputy Secretary Clinical Innovation and Research
Chief Executive Agency for Clinical Innovation at NSW Health

Dr. Jean-Frédéric Levesque currently serves as the Deputy Secretary, Clinical Innovation and Research, and Chief Executive of the Agency for Clinical Innovation at NSW Health. Additionally, he holds the position of Adjunct Professor at the Centre for Primary Health Care and Equity, University of New South Wales. With over 150 peer-reviewed publications, his impactful research on healthcare access and inequity has garnered over 2,000 citations.

Posted in Uncategorized

Drug Discovery Webinar April 18, 2024 – “THerapeutic INnovations for Kids” Advanced Therapeutics Enabling Program

Join us for an illuminating webinar on April 18, 2024, where clinicians and researchers are invited to delve into the opportunities offered by the THerapeutic INnovations for Kids (THINK) Advanced Therapeutics Enabling Program, funded by Luminesce Alliance.

Led by Associate Professor Greg Arndt, the Head of Drug Discovery at the Children’s Cancer Institute, the THINK webinar will serve as a gateway to understanding THINK’s pivotal role in end-to-end drug discovery and development. Learn about the process for accessing THINK and how potential projects are reviewed and selected.

Whether you’re an experienced researcher or a clinician eager to contribute to pediatric healthcare advancements, this webinar provides invaluable insights into joining the THINK community. Register here.

The THINK Advanced Therapeutic Enabling Platform focus spans childhood cancers, genetic diseases, and neurodevelopmental disorders, reflecting Luminesce Alliance’s commitment to addressing critical paediatric health challenges.

Posted in Uncategorized